JP2011148894A5 - - Google Patents

Download PDF

Info

Publication number
JP2011148894A5
JP2011148894A5 JP2010010696A JP2010010696A JP2011148894A5 JP 2011148894 A5 JP2011148894 A5 JP 2011148894A5 JP 2010010696 A JP2010010696 A JP 2010010696A JP 2010010696 A JP2010010696 A JP 2010010696A JP 2011148894 A5 JP2011148894 A5 JP 2011148894A5
Authority
JP
Japan
Prior art keywords
oxyl
tetramethylpiperidine
tempo
derivatives
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010010696A
Other languages
English (en)
Japanese (ja)
Other versions
JP5493905B2 (ja
JP2011148894A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010010696A priority Critical patent/JP5493905B2/ja
Priority claimed from JP2010010696A external-priority patent/JP5493905B2/ja
Publication of JP2011148894A publication Critical patent/JP2011148894A/ja
Publication of JP2011148894A5 publication Critical patent/JP2011148894A5/ja
Application granted granted Critical
Publication of JP5493905B2 publication Critical patent/JP5493905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010010696A 2010-01-21 2010-01-21 ジエン系ゴム組成物 Active JP5493905B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010010696A JP5493905B2 (ja) 2010-01-21 2010-01-21 ジエン系ゴム組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010010696A JP5493905B2 (ja) 2010-01-21 2010-01-21 ジエン系ゴム組成物

Publications (3)

Publication Number Publication Date
JP2011148894A JP2011148894A (ja) 2011-08-04
JP2011148894A5 true JP2011148894A5 (enExample) 2012-08-30
JP5493905B2 JP5493905B2 (ja) 2014-05-14

Family

ID=44536190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010010696A Active JP5493905B2 (ja) 2010-01-21 2010-01-21 ジエン系ゴム組成物

Country Status (1)

Country Link
JP (1) JP5493905B2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102377922B1 (ko) * 2021-05-13 2022-03-25 중앙아스콘(주) 저소음형 pcm 개질 순환 배수성 아스팔트 콘크리트 조성물
KR102377919B1 (ko) * 2021-05-13 2022-03-25 중앙아스콘(주) 저소음형 pcm 개질 순환 아스팔트 콘크리트 조성물
JP7703144B2 (ja) * 2021-06-30 2025-07-07 住友ゴム工業株式会社 空気入りタイヤ
JP7703143B2 (ja) * 2021-06-30 2025-07-07 住友ゴム工業株式会社 空気入りタイヤ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4046734B2 (ja) * 2005-01-18 2008-02-13 横浜ゴム株式会社 ポリマーの変性方法
JP2006274174A (ja) * 2005-03-30 2006-10-12 Yokohama Rubber Co Ltd:The 粘度安定化再生ゴム及びそれを含むゴム組成物
EP2039705A4 (en) * 2006-07-07 2009-11-11 Yokohama Rubber Co Ltd MODIFIED RUBBER AND RUBBER COMPOSITION COMPRISING THEREOF
JP4286300B2 (ja) * 2007-04-16 2009-06-24 横浜ゴム株式会社 変性ポリマー

Similar Documents

Publication Publication Date Title
CY2015009I1 (el) Ινδολινονες υποκατεστημενες στη θεση 6, η παραγωγη αυτων και η χρηση αυτων ως φαρμακευτικα μεσα
NO2019042I1 (no) Talazoparib, eventuelt i form av et farmasøytisk aksepterbart salt
NO2020035I1 (no) cefiderokol, eventuelt på formen av et farmasøytisk akseptabelt salt eller solvat
NO2020027I1 (no) glasdegib, eventuelt i form av et farmasøytisk akseptabelt salt, inkludert maleatsaltet
NL301049I2 (nl) crisaborole, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NO2020018I1 (no) Darolutamide, optionally in the form of a pharmaceutically acceptable salt or ester thereof
EP1984009A4 (en) PHARMACEUTICAL COMPOSITIONS WITH IMPROVED STABILITY
EP2351581A4 (en) VACCINE COMPOSITION AGAINST MALE AND CLAUSE DISEASE AND PREPARATION METHOD THEREFOR
BRPI0821276A2 (pt) Produto, e, uso do produto
JP2013523835A5 (enExample)
JP2007169302A5 (enExample)
IL201796A (en) Indole-3-Inglet or its pharmaceutical salts for use in the treatment of dermal lesion caused by papillomavirus
AR082688A1 (es) Uso de aglomerantes para preparar formulaciones estables al almacenamiento
EP2019687A4 (en) ANTI-STREPTOCOCCAL VACCINE
EP2121734A4 (en) MODIFIED FLAGELLINE WITH IMPROVED TOLL LIKE RECEPTOR 5
EP2588124A4 (en) UNIQUE CARBON CANNULA / SIRNA COMPLEXES AND METHOD THEREFOR
FR2922209B1 (fr) 5,6-DIARYLES PYRIDINES SUBSTITUES EN POSITION 2 et 3, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE.
JP2011148894A5 (enExample)
CL2008001795A1 (es) Uso de un antagonista par1 en el tratamiento de la fibrilacion atrial.
JP2009263366A5 (enExample)
EP2551266A4 (en) 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof
PT2188258E (pt) Compostos de nicotinamida substituídos e sua utilização em meios medicinais
JP2006305390A5 (enExample)
JP2013512203A5 (enExample)
JP2012501302A5 (enExample)